Women have sued Sanofi-Aventis, Sandoz, and Actavis (a Teva Pharmaceuticals company now) alleging the companies failed to warn women of the risk of permanent hair loss associated with use of a drug called Taxotere.
There are at least 300 cases filed in New Jersey, where the Court recently agreed to consolidate the cases before Judge James F. Hyland in Middlesex County. Women from New Jersey, as well as Maryland, Ohio, and Connecticut are included in this action. Now the cases will be litigated together, which generally is more cost-effective, efficient, and produces consistent results among plaintiffs.
What is Taxotere?
Taxotere is a chemotherapy drug that interferes with a cancer cell’s most basic functions. Taxotere is currently one of the most popular drugs used to treat breast cancer. However, it is also sometimes used during treatment for cancers of the lung, stomach, head, neck, and prostate. Some patients taking Taxotere have reported that their hair loss became permanent, a condition known as alopecia.